Article

OWL members connect at ASCRS

Ophthalmic Women Leaders (OWL) will hold a networking reception and meeting Monday, April 12, from 5 to 7 p.m. at the Westin Boston Waterfront Hotel. The event will take place during the annual meeting of the American Society of Cataract and Refractive Surgery.

Boston

-Ophthalmic Women Leaders (OWL) will hold a networking reception and meeting Monday, April 12, from 5 to 7 p.m. at the Westin Boston Waterfront Hotel. The event will take place during the annual meeting of the American Society of Cataract and Refractive Surgery.

The evening program is designed to help attendees demystify social media and help them to use new media tools to get “plugged in.” The event is free to members and $15 for non-members.

In addition, OWL members are welcome to visit the OWL Sanctuary, where Internet access, bottled water/toiletries, and meeting spaces are among the amenities. The lounge is free to members and will be open 10 a.m. to 5 p.m., Saturday through Monday, and from 10 a.m. to 2 p.m. Tuesday. The lounge is located in the Boston Convention and Exhibition Center, near the Hall B entrance and technology station.

Contact Molly Schar, OWL executive director, at 415/751-2401 or

mschar@owlsite.org

for more information.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
© 2025 MJH Life Sciences

All rights reserved.